vidarabine phosphate and Uterine Neoplasms

vidarabine phosphate has been researched along with Uterine Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberts, DS; Green, S; Miller, TP; Stephens, RL; Stock-Novack, DL; Surwit, EA; Von Hoff, DD1
Bodey, GP; Kavanagh, JJ; Krakoff, IH1

Trials

1 trial(s) available for vidarabine phosphate and Uterine Neoplasms

ArticleYear
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.
    American journal of clinical oncology, 1991, Volume: 14, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Middle Aged; Uterine Neoplasms; Vidarabine Phosphate

1991

Other Studies

1 other study(ies) available for vidarabine phosphate and Uterine Neoplasms

ArticleYear
Phase I study of fludarabine (2-fluoro-ara-AMP).
    European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:9

    Topics: Adult; Aged; Agranulocytosis; Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Choriocarcinoma; Drug Evaluation; Female; Humans; Middle Aged; Pregnancy; Rhabdomyosarcoma; Sarcoma, Ewing; Thrombocytopenia; Uterine Cervical Neoplasms; Uterine Neoplasms; Vidarabine Phosphate

1985